Experts’ Analysis on Russia’s registration of the world’s first new coronavirus vaccine

China News Agency Beijing on August 12, after Russia announced the registration of the world’s first new coronavirus vaccine, its registration caused controversy because it had not yet completed phase III clinical trials. China has novel coronavirus pneumonia vaccines and drug research and development standards, 12 experts said. On the 11th local time, Russian President Vladimir Putin revealed that Russia has registered the world’s first new coronavirus vaccine, saying it “can form stable immunity and has passed all tests” and “should be mass-produced in the shortest time”. According to the website of the Russian Ministry of health, the vaccine is a human adenovirus vector vaccine developed by the National Research Center for epidemiology and microbiology of gamaliya. It has passed a variety of animal tests and clinical tests of two groups of volunteers. < / P > < p > for the new coronavirus vaccine registered in Russia, there are different reactions. Some people, including fudge, director of the National Institute of allergy and infectious diseases, questioned the idea that the vaccine could be used on a large scale. According to Russian media reports, some Russian experts also called for a delay in vaccine registration. However, another voice thinks that the National Research Center of epidemiology and microbiology in Canada has more than ten years of experience in vaccine research and development, and the technology used in the development of new coronavirus vaccine has also been used. In view of the emergency situation, it is not necessary to delay the registration. China’s experts China’s novel coronavirus pneumonia vaccine research center,

, said that this does not mean that Russia has been in the forefront of the new crown vaccine for pneumonia, and that the fastest way is still China and the United States. Liu Junjian, vice president of Xinda biological new drug research, said at the pharmaceutical innovation frontier media salon held in Beijing on the 12th that both China and the United States have entered the phase III clinical trials of newly developed vaccines and drugs. “In particular, on July 27, the two pharmaceutical companies announced that the phase III clinical trials of the new coronavirus vaccine were launched, recruiting 30000 volunteers respectively.”. Yang zhanqiu, a professor at the Institute of Virology, School of basic medicine, Department of medicine, Wuhan University, believes that the progress made by Russia will promote vaccine development in China, the United States and even the world.